The Association of Dietary Cholesterol and Fatty Acids with Dyslipidemia in Chinese Metropolitan Men and Women
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Population
2.2. Dietary Assessment
2.3. Potential Confounders
2.4. Laboratory Measurements
2.5. Definition of Dyslipidaemia
2.6. Statistical Analyses
3. Results
3.1. Characteristics of Participants
3.2. Linear Regression between Dietary Cholesterol and Serum Cholesterol
3.3. Quintiles of Dietary Cholesterol Intake and Dyslipidemia Risk
4. Discussion
5. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
Appendix A
Item No | Recommendation | Check Notes by the Author | |
---|---|---|---|
Title and abstract | 1 | (a) Indicate the study’s design with a commonly used term in the title or the abstract | (a) A descriptive statement was revised instead of the previous definitive one. |
(b) Provide in the abstract an informative and balanced summary of what was done and what was found | (b) Conclusive statements in the abstract were revised to use appropriate language for observational studies. | ||
Introduction | Introduction | ||
Background/rationale | 2 | Explain the scientific background and rationale for the investigation being reported | Background and rationale were clearly explained. |
Objectives | 3 | State specific objectives, including any prespecified hypotheses | Objectives were stated. A sentence was revised according to appropriate describing of observational studies. |
Methods | Methods | ||
Study design | 4 | Present key elements of study design early in the paper | Clearly stated the design of present study. |
Setting | 5 | Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection | Described the setting, locations, and relevant dates. Described there was no settings that might affect the dietary intake or nutritional status of the participants. |
Participants | 6 | (a) Give the eligibility criteria, and the sources and methods of selection of participants | (a) The criteria and methods of selection of participants were reported. |
Variables | 7 | Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable | Defined all outcomes, dietary intake, predictors and potential confounders. Dyslipidaemia definition was given. |
Data sources/measurement | 8 * | For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group | The sources of data and details of methods of dietary and laboratory measurements were given. |
Bias | 9 | Describe any efforts to address potential sources of bias | Described potential confounders and their assessment. |
Study size | 10 | Explain how the study size was arrived at | Explained the study size and the size of the participants’ data used in current study were given. |
Quantitative variables | 11 | Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why | Explaind the reasonable scope of the quantitative variables (energy intakes) and the data within the scope were chosen. |
Statistical methods | 12 | (a) Describe all statistical methods, including those used to control for confounding | (a) Described all statistical methods, including those used to control for confounding |
(b) Describe any methods used to examine subgroups and interactions | (b) Described methods used to examine subgroups | ||
(c) Explain how missing data were addressed | (c) Explained in the study population that the records with missing data were excluded. | ||
(d) If applicable, describe analytical methods taking account of sampling strategy | (d) Described estimation and on ICC considering the sampling and decision on using fixed models. | ||
(e) Describe any sensitivity analyses | (e) Described covariates selection procedure and the parameters setting. | ||
Results | Results | ||
Participants | 13 * | (a) Report numbers of individuals at each stage of study—e.g., numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed | (a) Reported numbers of individuals’ in the current analysis. The number of individuals at each stage of study was reported in the methods part. |
(b) Give reasons for non-participation at each stage | (b) Gave reasons for non-participation at each stage in the methods part. | ||
(c) Consider use of a flow diagram | (c) Not using flow diagram. | ||
Descriptive data | 14 * | (a) Give characteristics of study participants (e.g., demographic, clinical, social) and information on exposures and potential confounders | (a) Gave characteristics of study participants and information on potential confounders. |
(b) Indicate number of participants with missing data for each variable of interest | (b) Records with missing data were excluded. | ||
Outcome data | 15 * | Report numbers of outcome events or summary measures | Reported serum lipids level and numbers of dyslipidaemia. |
Main results | 16 | (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (e.g., 95% confidence interval). Make clear which confounders were adjusted for and why they were included | (a) Gave confounder-adjusted estimates and their precision (e.g., 95% confidence interval). Stated confounders adjusted for. The covariates selection was explained in the methods part. |
(b) Report category boundaries when continuous variables were categorized | (b) Reported the dietary cholesterol category boundaries when it was categorized in the logistic regression model. | ||
(c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period | |||
Other analyses | 17 | Report other analyses done—e.g., analyses of subgroups and interactions, and sensitivity analyses | Reported the analyses of sex subgroups. |
Discussion | Discussion | ||
Key results | 18 | Summarise key results with reference to study objectives | Summarised key results with reference to study objectives. |
Limitations | 19 | Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias | Discussed four limitations of the current study and potential bias or imprecision. |
Interpretation | 20 | Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence | Gave a cautious overall interpretation of results in the descriptive statements. |
Generalisability | 21 | Discuss the generalisability (external validity) of the study results | Discussed the consistency and inconsistency with other studies. |
Other information | Other information | ||
Funding | 22 | Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based | Gave the source of funding and the role of the funders for the present study. |
References
- World Health Organization. Global Status Report on Noncommunicable Diseases 2014; World Health Organization: Geneva, Switzerland, 2014. [Google Scholar]
- Lewington, S.; Whitlock, G.; Clarke, R.; Sherliker, P.; Emberson, J.; Halsey, J.; Qizilbash, N.; Peto, R.; Collins, R. Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007, 370, 1829–1839. [Google Scholar] [CrossRef] [PubMed]
- Grundy, S.M.; Cleeman, J.I.; Daniels, S.R.; Donato, K.A.; Eckel, R.H.; Franklin, B.A.; Gordon, D.J.; Krauss, R.M.; Savage, P.J.; Smith, S.J.; et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112, 2735–2752. [Google Scholar] [CrossRef] [PubMed]
- Grundy, S.M.; Cleeman, J.I.; Merz, C.N.; Brewer, H.J.; Clark, L.T.; Hunninghake, D.B.; Pasternak, R.C.; Smith, S.J.; Stone, N.J. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004, 110, 227–239. [Google Scholar] [CrossRef] [PubMed]
- Reiner, Z.; Catapano, A.L.; De Backer, G.; Graham, I.; Taskinen, M.R.; Wiklund, O.; Agewall, S.; Alegria, E.; Chapman, M.J.; Durrington, P.; et al. ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur. Heart J. 2011, 32, 1769–1818. [Google Scholar] [CrossRef] [PubMed]
- Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285, 2486–2497. [Google Scholar]
- Silverman, M.G.; Ference, B.A.; Im, K.; Wiviott, S.D.; Giugliano, R.P.; Grundy, S.M.; Braunwald, E.; Sabatine, M.S. Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis. JAMA 2016, 316, 1289–1297. [Google Scholar] [CrossRef] [PubMed]
- Berger, S.; Raman, G.; Vishwanathan, R.; Jacques, P.F.; Johnson, E.J. Dietary cholesterol and cardiovascular disease: A systematic review and meta-analysis. Am. J. Clin. Nutr. 2015, 102, 276–294. [Google Scholar] [CrossRef] [PubMed]
- Stamler, J. Diet-heart: A problematic revisit. Am. J. Clin. Nutr. 2010, 91, 497–499. [Google Scholar] [CrossRef] [PubMed]
- Lecerf, J.; de Lorgeril, M. Dietary cholesterol: From physiology to cardiovascular risk. Br. J. Nutr. 2011, 106, 6–14. [Google Scholar] [CrossRef] [PubMed]
- Kapourchali, F.R.; Surendiran, G.; Goulet, A.; Moghadasian, M.H. The Role of Dietary Cholesterol in Lipoprotein Metabolism and Related Metabolic Abnormalities: A Mini-review. Crit. Rev. Food Sci. Nutr. 2016, 56, 2408–2415. [Google Scholar] [CrossRef] [PubMed]
- Fernandez, M.L. Effects of eggs on plasma lipoproteins in healthy populations. Food Funct. 2010, 1, 156–160. [Google Scholar] [CrossRef] [PubMed]
- Barona, J.; Fernandez, M.L. Dietary cholesterol affects plasma lipid levels, the intravascular processing of lipoproteins and reverse cholesterol transport without increasing the risk for heart disease. Nutrients 2012, 4, 1015–1025. [Google Scholar] [CrossRef] [PubMed]
- U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans 2010; U.S. Government Printing Office: Washington, DC, USA, 2010; ISBN 9781497374768.
- Van Horn, L.; Carson, J.A.; Appel, L.J.; Burke, L.E.; Economos, C.; Karmally, W.; Lancaster, K.; Lichtenstein, A.H.; Johnson, R.K.; Thomas, R.J.; et al. Recommended Dietary Pattern to Achieve Adherence to the American Heart Association/American College of Cardiology (AHA/ACC) Guidelines: A Scientific Statement From the American Heart Association. Circulation 2016, 134, e505–e529. [Google Scholar] [CrossRef] [PubMed]
- Chinese Nutrition Society. Dietary Guidelines for Chinese 2016; People’s Medical Publishing House: Beijing, China, 2016; ISBN 9787117222143. [Google Scholar]
- Li, Y.; Hruby, A.; Bernstein, A.M.; Ley, S.H.; Wang, D.D.; Chiuve, S.E.; Sampson, L.; Rexrode, K.M.; Rimm, E.B.; Willett, W.C.; et al. Saturated Fats Compared With Unsaturated Fats and Sources of Carbohydrates in Relation to Risk of Coronary Heart Disease. J. Am. Coll. Cardiol. 2015, 66, 1538–1548. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dehghan, M.; Mente, A.; Zhang, X.; Swaminathan, S.; Li, W.; Mohan, V.; Iqbal, R.; Kumar, R.; Wentzel-Viljoen, E.; Rosengren, A.; et al. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): A prospective cohort study. Lancet 2017, 390, 2050–2062. [Google Scholar] [CrossRef]
- Katz, D.L. Diet and Health: Puzzling Past Paradox to PURE Understanding. Available online: https://www.linkedin.com/pulse/diet-health-puzzling-past-paradox-pure-understanding-david/?trk=mp-reader-card (accessed on 8 July 2018).
- Yang, Y.; Wang, G.; Pan, X. Chinese Food Composition Book 2; Peking University Medical Press: Beijing, China, 2005; pp. 75–216. ISBN 9787810716789. [Google Scholar]
- Yang, Y.; Wang, G.; Pan, X. Chinese Food Composition Book 1; Peking University Medical Press: Beijing, China, 2009; pp. 45–192. ISBN 9787811167276. [Google Scholar]
- Fernandez, M.L.; Webb, D. The LDL to HDL cholesterol ratio as a valuable tool to evaluate coronary heart disease risk. J. Am. Coll. Nutr. 2008, 27, 1–5. [Google Scholar] [CrossRef] [PubMed]
- Stampfer, M.J.; Sacks, F.M.; Salvini, S.; Willett, W.C.; Hennekens, C.H. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N. Engl. J. Med. 1991, 325, 373–381. [Google Scholar] [CrossRef] [PubMed]
- Weggemans, R.M.; Zock, P.L.; Katan, M.B. Dietary cholesterol from eggs increases the ratio of total cholesterol to high-density lipoprotein cholesterol in humans: A meta-analysis. Am. J. Clin. Nutr. 2001, 73, 885–891. [Google Scholar] [CrossRef] [PubMed]
- Blesso, C.N.; Fernandez, M.L. Dietary Cholesterol, Serum Lipids, and Heart Disease: Are Eggs Working for or Against You? Nutrients 2018, 10, 426. [Google Scholar] [CrossRef] [PubMed]
- Mente, A.; Dehghan, M.; Rangarajan, S.; McQueen, M.; Dagenais, G.; Wielgosz, A.; Lear, S.; Li, W.; Chen, H.; Yi, S.; et al. Association of dietary nutrients with blood lipids and blood pressure in 18 countries: A cross-sectional analysis from the PURE study. Lancet Diabetes Endocrinol. 2017, 5, 774–787. [Google Scholar] [CrossRef]
- Pang, S.J.; Jia, S.S.; Man, Q.Q.; Song, S.; Li, Y.Q.; Song, P.K.; Zhao, W.H.; Zhang, J. Dietary Cholesterol in the Elderly Chinese Population: An Analysis of CNHS 2010–2012. Nutrients 2017, 9, 934. [Google Scholar] [CrossRef] [PubMed]
- Song, S.; Paik, H.Y.; Park, M.; Song, Y. Dyslipidemia patterns are differentially associated with dietary factors. Clin. Nutr. 2016, 35, 885–891. [Google Scholar] [CrossRef] [PubMed]
- Houston, D.K.; Ding, J.; Lee, J.S.; Garcia, M.; Kanaya, A.M.; Tylavsky, F.A.; Newman, A.B.; Visser, M.; Kritchevsky, S.B. Dietary fat and cholesterol and risk of cardiovascular disease in older adults: The Health ABC Study. Nutr. Metab. Cardiovasc. Dis. 2011, 21, 430–437. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Casagrande, S.S.; Cowie, C.C. Trends in dietary intake among adults with type 2 diabetes: NHANES 1988–2012. J. Hum. Nutr. Diet. 2017, 30, 479–489. [Google Scholar] [CrossRef] [PubMed]
- Lajous, M.; Bijon, A.; Fagherazzi, G.; Balkau, B.; Boutron-Ruault, M.; Clavel-Chapelon, F. Egg and cholesterol intake and incident type 2 diabetes among French women. Br. J. Nutr. 2015, 114, 1667–1673. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Metcalf, P.A.; Scragg, R.R.; Sundborn, G.; Jackson, R. Dietary intakes of Pacific ethnic groups and European people. Pac. Health Dialog. 2014, 20, 73–80. [Google Scholar] [PubMed]
- Rhee, E.; Ryu, S.; Lee, J.; Lee, S.H.; Cheong, E.; Park, S.E.; Park, C.; Won, Y.S.; Kim, J.M.; Cho, D.; et al. The association between dietary cholesterol intake and subclinical atherosclerosis in Korean adults: The Kangbuk Samsung Health Study. J. Clin. Lipidol. 2017, 11, 432–441. [Google Scholar] [CrossRef] [PubMed]
- Jacobson, T.A.; Maki, K.C.; Orringer, C.E.; Jones, P.H.; Kris-Etherton, P.; Sikand, G.; La Forge, R.; Daniels, S.R.; Wilson, D.P.; Morris, P.B.; et al. National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2. J. Clin. Lipidol. 2015, 9, S1S–S122. [Google Scholar] [CrossRef] [PubMed]
- Ginsberg, H.N.; Karmally, W.; Siddiqui, M.; Holleran, S.; Tall, A.R.; Rumsey, S.C.; Deckelbaum, R.J.; Blaner, W.S.; Ramakrishnan, R. A dose-response study of the effects of dietary cholesterol on fasting and postprandial lipid and lipoprotein metabolism in healthy young men. Arterioscler. Thromb. 1994, 14, 576–586. [Google Scholar] [CrossRef] [PubMed]
- Oh, K. Dietary Fat Intake and Risk of Coronary Heart Disease in Women: 20 Years of Follow-up of the Nurses’ Health Study. Am. J. Epidemiol. 2005, 161, 672–679. [Google Scholar] [CrossRef] [PubMed]
- Erkkila, A.; de Mello, V.D.; Riserus, U.; Laaksonen, D.E. Dietary fatty acids and cardiovascular disease: An epidemiological approach. Prog. Lipid Res. 2008, 47, 172–187. [Google Scholar] [CrossRef] [PubMed]
- Mensink, R.P.; Zock, P.L.; Kester, A.D.; Katan, M.B. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: A meta-analysis of 60 controlled trials. Am. J. Clin. Nutr. 2003, 77, 1146–1155. [Google Scholar] [CrossRef] [PubMed]
- Siri-Tarino, P.W.; Sun, Q.; Hu, F.B.; Krauss, R.M. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am. J. Clin. Nutr. 2010, 91, 535–546. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chowdhury, R.; Warnakula, S.; Kunutsor, S.; Crowe, F.; Ward, H.A.; Johnson, L.; Franco, O.H.; Butterworth, A.S.; Forouhi, N.G.; Thompson, S.G.; et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: A systematic review and meta-analysis. Ann. Intern. Med. 2014, 160, 398–406. [Google Scholar] [CrossRef] [PubMed]
- Zhang, M.; Deng, Q.; Wang, L.; Huang, Z.; Zhou, M.; Li, Y.; Zhao, Z.; Zhang, Y.; Wang, L. Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: A nationally representative survey of 163,641 adults. Int. J. Cardiol. 2018, 260, 196–203. [Google Scholar] [CrossRef] [PubMed]
- Hegsted, D.M. Serum-cholesterol response to dietary cholesterol: A re-evaluation. Am. J. Clin. Nutr. 1986, 44, 299–305. [Google Scholar] [CrossRef] [PubMed]
- McGill, H.J. The relationship of dietary cholesterol to serum cholesterol concentration and to atherosclerosis in man. Am. J. Clin. Nutr. 1979, 32, 2664–2702. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jansen, R.; Batista, S.; Brooks, A.I.; Tischfield, J.A.; Willemsen, G.; van Grootheest, G.; Hottenga, J.J.; Milaneschi, Y.; Mbarek, H.; Madar, V.; et al. Sex differences in the human peripheral blood transcriptome. BMC Genom. 2014, 15, 33. [Google Scholar] [CrossRef] [PubMed]
- Madssen, E.; Laugsand, L.E.; Wiseth, R.; Morkedal, B.; Platou, C.; Vatten, L.; Janszky, I. Risk of acute myocardial infarction: Dyslipidemia more detrimental for men than women. Epidemiology 2013, 24, 637–642. [Google Scholar] [CrossRef] [PubMed]
- Weggemans, R.M.; Zock, P.L.; Urgert, R.; Katan, M.B. Differences between men and women in the response of serum cholesterol to dietary changes. Eur. J. Clin. Investig. 1999, 29, 827–834. [Google Scholar] [CrossRef]
- Gazzola, K.; Reeskamp, L.; van den Born, B. Ethnicity, lipids and cardiovascular disease. Curr. Opin. Lipidol. 2017, 28, 225–230. [Google Scholar] [CrossRef] [PubMed]
All | Male | Female | p-Value | |
---|---|---|---|---|
n (%) | 3850 (100.0) | 1838 (47.7) | 2012 (52.3) | |
Age, % | 0.513 | |||
18–44 years | 31.3 | 30.7 | 32.0 | |
45–49 years | 35.4 | 35.2 | 35.6 | |
60 years | 33.3 | 34.1 | 32.5 | |
Ethnicity, % | 0.050 | |||
Hans (ethnic majority) | 99.5 | 99.7 | 99.2 | |
Other minorities | 0.5 | 0.3 | 0.8 | |
Years of education, % | <0.001 | |||
≤9 years | 53.9 | 49.4 | 58.1 | |
9–12 years | 23.9 | 26.1 | 21.9 | |
>12 years | 22.2 | 24.6 | 20.0 | |
Yearly Income,% | 0.523 | |||
Above average level (>60,000 RMB) | 7.8 | 7.3 | 8.2 | |
Average level (30,000–59,999 RMB) | 30.9 | 32.2 | 29.9 | |
Below average level (<30,000 RMB) | 56.8 | 55.8 | 57.7 | |
No answer | 4.5 | 4.8 | 4.2 | |
Smoking Status, % | <0.001 | |||
Never smoker | 71.0 | 41.0 | 98.8 | |
Former smoker | 5.4 | 10.8 | 0.4 | |
Current smoker | 23.6 | 48.3 | 0.8 | |
Physical Activity Level, % | <0.001 | |||
Sedentary | 84.5 | 79.4 | 89.0 | |
Moderate | 13.6 | 17.5 | 10.1 | |
Vigorous | 2.0 | 3.1 | 0.9 | |
Dietary intake | ||||
Energy, kcal/day (SE 1) | 1679.0 (9.2) | 1826.2 (13.3) | 1542.9 (12.1) | <0.0001 |
Carbohydrate, g/day (SE) | 198.0 (1.3) | 212.4 (1.9) | 184.6 (1.7) | <0.0001 |
Protein, g/day (SE) | 64.0 (0.4) | 69.3 (0.7) | 59.1 (0.6) | <0.0001 |
Total fat, g/day (SE) | 71.5 (0.6) | 77.9 (0.9) | 65.8 (0.8) | <0.0001 |
SFAs 1, g/day (SE) | 15.4 (0.1) | 16.7 (0.2) | 14.2 (0.2) | <0.0001 |
MUFAs 1, g/day (SE) | 26.0 (0.2) | 28.6 (0.4) | 23.7 (0.3) | <0.0001 |
PUFAs 1, g/day (SE) | 20.9 (0.2) | 22.6 (0.4) | 19.3 (0.3) | <0.0001 |
Dietary cholesterol, mg/day (SE) | 377.8 (3.5) | 399.1 (5.1) | 358.0 (4.8) | <0.0001 |
BMI 1 (kg/m2), % | <0.001 | |||
Underweight (<18.5) | 4.4 | 3.8 | 4.9 | |
Normal weight (18.5–23.9) | 49.5 | 45.1 | 53.6 | |
Overweight (24.0–27.9) | 35.2 | 39.9 | 30.8 | |
Obese (≥28.0) | 11.0 | 11.2 | 10.8 | |
Serum lipids profile | ||||
TC, mg/dL (SE) 1 | 182.9 (0.6) | 179.1 (0.8) | 186.3 (0.8) | <0.001 |
LDL-C, mg/dL (SE) 1 | 112.2 (0.6) | 111.5 (0.8) | 112.9 (0.8) | <0.001 |
HDL-C, mg/dL (SE) 1 | 56.5 (0.3) | 53.5 (0.4) | 59.2 (0.4) | <0.001 |
Triglycerides, mg/dL (SE) | 133.5 (1.8) | 145.8 (2.9) | 122.1 (2.3) | <0.001 |
Dyslipidemia 2 | ||||
High TC, % | 5.8 | 4.0 | 7.4 | <0.001 |
High LDL-C, % | 7.6 | 6.4 | 8.6 | 0.027 |
Low HDL-C, % | 20.9 | 14.8 | 26.3 | <0.001 |
High triglycerides, % | 27.3 | 31.3 | 23.6 | <0.001 |
TC | LDL-C | HDL-C | |||||||
β 2 | 95% CI | p-Value for Trend | β | 95% CI | p-Value for Trend | β | 95% CI | p-Value for Trend | |
All | |||||||||
Cholesterol | 0.64 | (0.13, 1.15) | 0.015 | 0.73 | (0.21,1.24) | 0.006 | 0.15 | (−0.08, 0.38) | 0.213 |
SFAs | 0.81 | (−0.68, 2.29) | 0.287 | 0.37 | (−1.17, 1.90) | 0.641 | 0.51 | (−0.18, 1.19) | 0.145 |
MUFAs | 0.53 | (−0.28, 1.35) | 0.200 | 0.07 | (−0.77, 0.92) | 0.863 | 0.32 | (−0.05, 0.70) | 0.093 |
PUFAs | 0.06 | (−0.74, 0.85) | 0.892 | 0.35 | (−0.47, 1.16) | 0.403 | 0.33 | (−0.03, 0.69) | 0.075 |
Male | |||||||||
Cholesterol | 0.27 | (−0.45, 1.00) | 0.459 | 0.43 | (−0.29, 1.16) | 0.239 | 0.00 | (−0.32, 0.32) | 0.995 |
SFAs | 0.94 | (−1.06, 2.95) | 0.357 | 0.80 | (−1.29, 2.88) | 0.454 | 0.32 | (−0.61, 1.25) | 0.501 |
MUFAs | 0.65 | (−0.44, 1.73) | 0.242 | 0.45 | (−0.67, 1.57) | 0.431 | 0.29 | (−0.22, 0.79) | 0.264 |
PUFAs | 0.48 | (−0.58, 1.53) | 0.375 | 0.71 | (−0.37, 1.79) | 0.199 | 0.34 | (−0.14, 0.82) | 0.169 |
Female | |||||||||
Cholesterol | 0.97 | (0.25, 1.68) | 0.008 | 0.94 | (0.22, 1.67) | 0.011 | 0.35 | (0.02, 0.67) | 0.036 |
SFAs | 0.45 | (−1.74, 2.63) | 0.689 | −0.44 | (−2.67, 1.80) | 0.701 | 0.85 | (−0.14, 1.84) | 0.094 |
MUFAs | 0.33 | (−0.88, 1.55) | 0.593 | −0.49 | (−1.75, 0.77) | 0.445 | 0.41 | (−0.15, 0.97) | 0.147 |
PUFAs | −0.45 | (−1.64, 0.75) | 0.463 | −0.18 | (−1.40, 1.04) | 0.775 | 0.33 | (−0.21, 0.88) | 0.227 |
LDL-C:HDL-C | TC:HDL-C | Triglycerides | |||||||
β | 95% CI | p-Value for Trend | β | 95% CI | p-Value for Trend | β | 95% CI | p-Value for Trend | |
All | |||||||||
Cholesterol | 0.01 | (0.00, 0.02) | 0.018 | 0.01 | (−0.01, 0.03) | 0.304 | 0.77 | (−0.90, 2.45) | 0.364 |
SFA | 0.00 | (−0.04, 0.03) | 0.801 | −0.03 | (−0.08, 0.02) | 0.242 | −2.49 | (−7.34, 2.36) | 0.314 |
MUFA | −0.01 | (−0.03, 0.01) | 0.318 | −0.02 | (−0.04, 0.01) | 0.226 | −0.73 | (−3.38, 1.92) | 0.589 |
PUFA | −0.01 | (−0.02, 0.01) | 0.513 | −0.02 | (−0.05, 0.00) | 0.092 | −1.88 | (−4.48, 0.72) | 0.156 |
Male | |||||||||
Cholesterol | 0.01 | (−0.01, 0.03) | 0.206 | 0.01 | (−0.02, 0.03) | 0.632 | 0.38 | (−2.18, 2.94) | 0.771 |
SFA | 0.00 | (−0.04, 0.05) | 0.888 | −0.03 | (−0.10, 0.04) | 0.441 | −3.91 | (−11.01, 3.19) | 0.280 |
MUFA | 0.00 | (−0.03, 0.02) | 0.810 | −0.02 | (−0.05, 0.02) | 0.435 | −1.52 | (−5.36, 2.32) | 0.437 |
PUFA | 0.00 | (−0.03, 0.02) | 0.897 | −0.02 | (−0.05, 0.02) | 0.416 | −1.41 | (−5.15, 2.33) | 0.460 |
Female | |||||||||
Cholesterol | 0.01 | (0.00, 0.03) | 0.093 | 0.01 | (−0.02, 0.03) | 0.527 | 0.93 | (−1.19, 3.06) | 0.390 |
SFA | −0.02 | (−0.07, 0.02) | 0.304 | −0.04 | (−0.11, 0.02) | 0.201 | −1.70 | (−8.16, 4.75) | 0.605 |
MUFA | −0.02 | (−0.05, 0.00) | 0.114 | −0.02 | (−0.06, 0.02) | 0.248 | 0.04 | (−3.55, 3.63) | 0.984 |
PUFA | −0.01 | (−0.04, 0.01) | 0.303 | −0.03 | (−0.07, 0.00) | 0.075 | −2.25 | (−5.78, 1.28) | 0.211 |
Quintiles of Dietary Cholesterol Intake (mg/day) | ||||||
---|---|---|---|---|---|---|
Q1 (<193.1) | Q2 (193.1–293.0) | Q3 (293.1–401.6) | Q4 (401.7–529.9) | Q5 (≥538.0) | ||
All (n = 3850) | ||||||
n | 770 | 770 | 770 | 770 | 770 | |
High TC | OR | Reference | 1.19 | 1.33 | 1.14 | 1.57 |
95% CI | (0.76, 1.87) | (0.85, 2.08) | (0.71, 1.81) | (1.01, 2.43) | ||
p-Value | 0.448 | 0.210 | 0.585 | 0.044 | ||
High LDL-C | OR | Reference | 0.98 | 1.04 | 1.10 | 1.59 |
95% CI | (0.63, 1.54) | (0.66, 1.64) | (0.70, 1.74) | (1.05, 2.42) | ||
p-Value | 0.931 | 0.858 | 0.666 | 0.030 | ||
Low HDL-C | OR | Reference | 0.99 | 0.85 | 1.03 | 0.83 |
95% CI | (0.75, 1.30) | (0.64, 1.13) | (0.78, 1.36) | (0.62, 1.11) | ||
p-Value | 0.914 | 0.256 | 0.843 | 0.207 | ||
High triglyceride | OR | Reference | 1.05 | 0.88 | 1.04 | 1.21 |
95% CI | (0.83, 1.33) | (0.69, 1.12) | (0.82, 1.32) | (0.96, 1.53) | ||
p-Value | 0.681 | 0.304 | 0.741 | 0.111 | ||
Male (n = 1838) | ||||||
n | 316 | 342 | 359 | 409 | 412 | |
High TC | OR | Reference | 1.47 | 1.40 | 0.73 | 1.51 |
95% CI | (0.64, 3.34) | (0.61, 3.17) | (0.29, 1.82) | (0.69, 3.32) | ||
p-Value | 0.361 | 0.426 | 0.494 | 0.305 | ||
High LDL-C | OR | Reference | 0.90 | 1.00 | 0.81 | 1.27 |
95% CI | (0.43, 1.87) | (0.49, 2.03) | (0.39, 1.69) | (0.66, 2.45) | ||
p-Value | 0.777 | 0.992 | 0.583 | 0.478 | ||
Low HDL-C | OR | Reference | 1.03 | 0.85 | 0.73 | 0.82 |
95% CI | (0.65, 1.65) | (0.53, 1.39) | (0.45, 1.19) | (0.52, 1.31) | ||
p-Value | 0.892 | 0.525 | 0.202 | 0.411 | ||
High triglyceride | OR | Reference | 1.38 | 1.01 | 1.15 | 1.33 |
95% CI | (0.97, 1.97) | (0.70, 1.44) | (0.81, 1.62) | (0.95, 1.87) | ||
p-Value | 0.072 | 0.978 | 0.436 | 0.100 | ||
Female (n = 2012) | ||||||
n | 454 | 428 | 411 | 361 | 358 | |
High TC | OR | Reference | 1.05 | 1.31 | 1.38 | 1.56 |
95% CI | (0.61, 1.81) | (0.77, 2.25) | (0.80, 2.37) | (0.91, 2.67) | ||
p-Value | 0.855 | 0.322 | 0.247 | 0.104 | ||
High LDL-C | OR | Reference | 1.00 | 1.05 | 1.33 | 1.84 |
95% CI | (0.56, 1.77) | (0.58, 1.89) | (0.75, 2.38) | (1.07, 3.16) | ||
p-Value | 0.998 | 0.882 | 0.332 | 0.027 | ||
Low HDL-C | OR | Reference | 0.96 | 0.86 | 1.29 | 0.82 |
95% CI | (0.68, 1.35) | (0.60, 1.23) | (0.91, 1.83) | (0.57, 1.19) | ||
p-Value | 0.815 | 0.414 | 0.157 | 0.303 | ||
High triglyceride | OR | Reference | 0.84 | 0.83 | 1.01 | 1.18 |
95% CI | (0.60, 1.16) | (0.59, 1.16) | (0.72, 1.41) | (0.85, 1.65) | ||
p-Value | 0.287 | 0.272 | 0.969 | 0.328 |
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Zhu, Z.; Wu, F.; Lu, Y.; Wang, Z.; Zang, J.; Yu, H.; Guo, C.; Jia, X.; Shen, X.; Ding, G. The Association of Dietary Cholesterol and Fatty Acids with Dyslipidemia in Chinese Metropolitan Men and Women. Nutrients 2018, 10, 961. https://doi.org/10.3390/nu10080961
Zhu Z, Wu F, Lu Y, Wang Z, Zang J, Yu H, Guo C, Jia X, Shen X, Ding G. The Association of Dietary Cholesterol and Fatty Acids with Dyslipidemia in Chinese Metropolitan Men and Women. Nutrients. 2018; 10(8):961. https://doi.org/10.3390/nu10080961
Chicago/Turabian StyleZhu, Zhenni, Fan Wu, Ye Lu, Zhengyuan Wang, Jiajie Zang, Huiting Yu, Changyi Guo, Xiaodong Jia, Xianbiao Shen, and Gangqiang Ding. 2018. "The Association of Dietary Cholesterol and Fatty Acids with Dyslipidemia in Chinese Metropolitan Men and Women" Nutrients 10, no. 8: 961. https://doi.org/10.3390/nu10080961
APA StyleZhu, Z., Wu, F., Lu, Y., Wang, Z., Zang, J., Yu, H., Guo, C., Jia, X., Shen, X., & Ding, G. (2018). The Association of Dietary Cholesterol and Fatty Acids with Dyslipidemia in Chinese Metropolitan Men and Women. Nutrients, 10(8), 961. https://doi.org/10.3390/nu10080961